Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 8/20 | 0.49 |
| ▸ | LY96 | Q9Y6Y9 | 6/20 | 0.48 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.47 |
| ▸ | TK2 | O00142 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Heptane SCHEMBL8771598 | 1.00 | TLR4 (0.49) | TLR4LY96LGALS8TK2 | |
| SCHEMBL8822080 | 1.00 | TLR4 (0.49) | TLR4LY96LGALS8TK2 | |
| SCHEMBL8771563 | 1.00 | TLR4 (0.49) | TLR4LY96LGALS8TK2 | |
| SCHEMBL8822072 | 1.00 | TLR4 (0.49) | TLR4LY96LGALS8TK2 | |
| SCHEMBL9346790 | 1.00 | TLR4 (0.49) | TLR4LY96LGALS8TK2 | |
| SCHEMBL8195199 | 1.00 | TLR4 (0.49) | TLR4LY96LGALS8TK2 | |
| SCHEMBL9347504 | 1.00 | TLR4 (0.49) | TLR4LY96LGALS8TK2 | |
| SCHEMBL9342585 | 0.94 | TLR4 (0.54) | TLR4LY96TK2 | |
| SCHEMBL11504109 | 0.93 | TLR4 (0.49) | TLR4LY96TK2 | |
| SCHEMBL6269517 | 0.93 | TLR4 (0.51) | TLR4LY96 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3891102-B1 | NANONETS FOR REMOVAL OF CONTAMINANTS FROM AQUEOUS SOLUTIONS, KITS THEREFOR AND METHODS OF THEIR USE | CARBONET NANOTECHNOLOGIES INC (CA) | 2024-04-17 | — | — | EP | disclosed |
| US-20230035776-A1 | NANONETS FOR REMOVAL OF CONTAMINANTS FROM AQUEOUS SOLUTIONS, KITS THEREFOR AND METHODS OF THEIR USE | CARBONET NANOTECHNOLOGIES INC. (CA) | 2023-02-02 | — | — | US | disclosed |
| EP-3891102-A1 | NANONETS FOR REMOVAL OF CONTAMINANTS FROM AQUEOUS SOLUTIONS, KITS THEREFOR AND METHODS OF THEIR USE | Carbonet Nanotechnologies Inc. (CA) | 2021-10-13 | — | — | EP | disclosed |
| WO-2020113330-A1 | NANONETS FOR REMOVAL OF CONTAMINANTS FROM AQUEOUS SOLUTIONS, KITS THEREFOR AND METHODS OF THEIR USE | CARBONET NANOTECHONOLOGIES INC. (CA) | 2020-06-11 | — | — | WO | disclosed |
| EP-1605950-A4 | NOVEL CHEMICAL ENTITIES AND METHODS FOR THEIR USE IN TREATMENT OF METABOLIC DISORDERS | ACCERA INC (US) | 2008-01-09 | — | — | EP | disclosed |
| WO-2006097348-A1 | USE OF AGENTS SUCH AS NONPOLYMERIC NITRIC OXIDE DONORS FOR MAKING THE LIPS FULL AGAIN AND/OR COLOURING THE LIPS | L'OREAL (FR) | 2006-09-21 | — | — | WO | disclosed |
| US-20060189545-A1 | Novel chemical entities and methods for their use in treatment of metabolic disorders | ACCERA, INC. | 2006-08-24 | — | — | US | disclosed |
| EP-1605950-A2 | NOVEL CHEMICAL ENTITIES AND METHODS FOR THEIR USE IN TREATMENT OF METABOLIC DISORDERS | Accera, Inc. (US) | 2005-12-21 | — | — | EP | disclosed |
| WO-2004077938-A2 | NOVEL CHEMICAL ENTITIES AND METHODS FOR THEIR USE IN TREATMENT OF METABOLIC DISORDERS | ACCERA INC. (US) | 2004-09-16 | — | — | WO | disclosed |
| EP-0566438-A1 | Method for the preparation of D-maltose monoesters with a high 6-0'-ester content and their use in the cosmetic, dental-care, pharmaceuticals and food stuff fields | L'OREAL (FR) | 1993-10-20 | — | — | EP | disclosed |
| US-4150114-A | ENHANCED PENETRATION | THE PROCTER & GAMBLE COMPANY (US) | 1979-04-17 | — | — | US | disclosed |
| US-4148893-A | SUGAR ESTER AND DIALKYL SULFOXIDE ENHANCE PENETRATION THROUGH SKIN | THE PROCTER & GAMBLE COMPANY (US) | 1979-04-10 | — | — | US | disclosed |
| US-4148874-A | ENHANCE PENETRATION OF PHARMOCOLOGICALLY ACTIVE AGENTS THROUGH THE SKIN | THE PROCTER & GAMBLE COMPANY (US) | 1979-04-10 | — | — | US | disclosed |
| US-4148917-A | PENETRATION | THE PROCTER & GAMBLE COMPANY (US) | 1979-04-10 | — | — | US | disclosed |
| US-4148924-A | Dermatological compositions | THE PROCTER & GAMBLE COMPANY (US) | 1979-04-10 | — | — | US | disclosed |
| US-4148887-A | SUGAR ESTER WITH A METHYL SULFOXIDE | THE PROCTER & GAMBLE COMPANY (US) | 1979-04-10 | — | — | US | disclosed |
| US-4130667-A | A SUCROSE ESTER AND A PHOSPHINE OXIDE | THE PROCTER & GAMBLE COMPANY (US) | 1978-12-19 | — | — | US | disclosed |
| US-4130643-A | STEROID, SUCROSE ESTER, SULFOXIDE | THE PROCTER & GAMBLE COMPANY (US) | 1978-12-19 | — | — | US | disclosed |
| US-4046886-A | SUGAR ESTER, PHOSPHINE OXIDE | THE PROCTER & GAMBLE COMPANY (US) | 1977-09-06 | — | — | US | disclosed |
| US-3952099-A | MICROBIOCIDE, SUGAR ESTER, SULFOXIDE | THE PROCTER & GAMBLE COMPANY (US) | 1976-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060189545-A1 | Novel chemical entities and methods for their use in treatment of metabolic disorders | BACE1, PC, PSEN2 | TLR4 2655/4885LY96 3781/4885LGALS8 504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.